Vivodyne
Accelerating drug discovery with lab-grown tissues, robotics and AI
Company Facts
About Vivodyne
Vivodyne accelerates drug discovery by combining lab-grown human tissues, robotics and AI to generate accurate preclinical test data.
What is Vivodyne?
Vivodyne is a biotechnology company focused on transforming how human biology is studied and therapeutics are developed. The company leverages advanced technologies, including lab-grown human organs and AI, to provide predictive human data before clinical trials.
Who is Vivodyne for?
Vivodyne's solutions are designed for biopharma companies and researchers involved in drug discovery and development. Their platform aims to improve the accuracy and efficiency of therapeutic development processes.
When was Vivodyne founded?
Vivodyne was founded in 2020, driven by the need to improve the translation of drug efficacy from animal studies to human trials.
Who founded Vivodyne?
Vivodyne was co-founded by Dr. Georgescu, who aimed to create a new platform for drug development that bridges the gap between animal studies and human clinical trials.
What is Vivodyne best known for?
Vivodyne is best known for its innovative platform that utilizes lab-grown human organs to generate predictive data for drug discovery, significantly enhancing the preclinical phase of therapeutic development.
Where AI Leaders Stay Informed
The latest AI intelligence, case studies, and research — delivered to your inbox every week.
Free to read. Unsubscribe anytime.
Is this your company?
Claim this profile to manage information and unlock premium features.